UNSPSC 51441619: Radium-223 dichloride

Radium Ra 223 Dichloride is a radiopharmaceutical containing the radioisotope radium-223. It is used to treat prostate cancer that has spread to the bones and cannot be treated with surgery and is used in patients who have metastatic bone cancer that is symptomatic with no visceral metastases.

UNSPSC 51441619 Radium-223 dichloride is a Commodity code that shows no meaningful alignment with recent state and local procurement activity. The code nominally describes a radioactive pharmaceutical used in oncology, yet the recent opportunities posted under this code span emergency medical services software (Collier County), long-term care pharmacy services (Dane County), general procurement networking events, aquatic facility operations, pharmacy benefits administration, pharmaceutical supply distribution for fire and EMS departments, mental health center prescription services, forensic drug standards, and naloxone distribution — none of which involve radium-223 dichloride or any radiopharmaceutical procurement. This appears to be a tagging mismatch at the state and local level rather than a code genuinely tracking radiopharmaceutical demand.

State and local procurement offices posting under this code are scattered across multiple jurisdictions and agency types — county health authorities, county fire departments, city emergency services, municipal medical centers, and county public health departments — but the actual goods and services solicited bear no relation to the code's stated commodity. The geographic spread spans Florida (Collier County, Dane County in Wisconsin, Washington County in Oregon, Tucson in Arizona, West Texas, and various Florida counties), yet the opportunities cluster around mainstream healthcare logistics (pharmacy services, EMS supplies, drug distribution) rather than specialty radiopharmaceuticals. Without recent solicitations for radium-223 dichloride itself, the code presents no actionable procurement signal for vendors in the radiopharmaceutical space.